semaglutide studies 2024 Effects of Once-Weekly on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial Study finds weight loss drug

Patients should never discontinue GLP-1 medication abruptly without medical guidance

Advances in therapeutic CRISPR/Cas9 genome editing

Maruderm Glutathione Brightening Milk Serum is a milky-textured serum formulated to enhance skin brightness while maintaining moisture balance and comfort

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

During the first month of semaglutide therapy, most patients experience modest weight losstypically 1-2% of baseline body weight, or approximately 2 to 5 poundsas the medication is initiated at lower doses

While localized issues may still pop up, the large-scale shortages of recent years appear to be resolving as manufacturers ramp up production